首页> 外文OA文献 >Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells

【2h】

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells

机译：用抑制性单克隆抗体靶向ADAM-17具有三阴性乳腺癌细胞中的抗肿瘤作用

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

AI期刊论文写作 >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
F Caiazza; P M McGowan; M Mullooly; A Murray; N Synnott; N ODonovan; L Flanagan; C J Tape; G Murphy; J Crown; M J Duffy;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells [J] . F Caiazza, P M McGowan, M Mullooly, British Journal of Cancer . 2015,第12期

机译：用抑制性单克隆抗体靶向ADAM-17在三阴性乳腺癌细胞中具有抗肿瘤作用
2. Synthetic human monoclonal antibody targets hIL1 receptor accessory protein chain with therapeutic potential in triple-negative breast cancer [J] . Zheng Pengfei, Zhang Yifu, Zhang Bin, Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie . 2018,第期

机译：合成人单克隆抗体靶向HIL1受体辅助蛋白链，具有三阴性乳腺癌治疗潜力
3. Radioimmunoimaging and targeting treatment in an immunocompetent murine model of triple-negative breast cancer using radiolabeled anti-programmed death-ligand 1 monoclonal antibody [J] . Pang Xiaoxi, Liu Meng, Wang Rongfu, Journal of Labelled Compounds and Radiopharmaceuticals . 2018,第11期

机译：使用放射性标记的抗程序死亡 - 配体1单克隆抗体在三重阴性乳腺癌免疫母鼠模型中放射免疫杂种和靶向治疗
4. THE INHIBITORY Fcy-RECEPTOR MB (CD32B) IS HIGHLY EXPRESSED ON CLONAL PLASMA CELLS FROM PATIENTS WITH SYSTEMIC LIGHT-CHAIN (AL) AMYLOIDOSIS AND PROVIDES A TARGET FOR MONOCLONAL ANTIBODY THERAPY [C] . P. Zhou, A B Olshen, E Bonvini, International Symposium on Amyloidosis . 2008

机译：抑制性FCY-受体MB（CD32B）对来自全身轻链（AL）淀粉样蛋白症患者的克隆血浆细胞高度表达，并为单克隆抗体治疗提供靶标
5. Identification of LRP8, CDCA7, and MLK4 as Novel Therapeutic Targets for Cancer Stem Cells in Triple-negative Breast Cancer [D] . Lin, Chang-Ching. 2018

机译：鉴定LRP8，CDCA7和MLK4作为三阴性乳腺癌中癌症干细胞的新疗法靶标
6. Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells [O] . F Caiazza, P M McGowan, M Mullooly, 2015

机译：用抑制性单克隆抗体靶向ADAM-17在三阴性乳腺癌细胞中具有抗肿瘤作用
7. Novel Antibodies Targeting MUC1-C Showed Anti-Metastasis and Growth-Inhibitory Effects on Human Breast Cancer Cells [O] . Min Jung Kim, Jong Rip Choi, Nara Tae, 2020

机译：靶向MUC1-C的新型抗体显示出对人乳腺癌细胞的抗转移和生长抑制作用
8. Targeting Breast Cancer Stem Cells in Triple-Negative Breast Cancer. [R] . 2015

机译：靶向三阴性乳腺癌中的乳腺癌干细胞。

Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells

著录项

引文网络

相似文献

相关主题

期刊订阅